Method of treating cancer with compositions comprising IL-31
AssigneeTechnion Research & Development Foundation Limited
InventorsElla Fremder, Ami Aronheim, Yuval Shaked
Life of this patent
Estimating the term…
Abstract
A method for treating cancer and/or preventing or reducing metastasis or treating angiogenesis related disorders comprising the step of administering IL-31 or peptide which is at least about 70%, homologous to the IL-31 sequence as set forth in SEQ ID No. 1.
Claims17
A method for treating cancer and/or preventing or reducing metastasis of a tumor in a subject comprising the step of administering a composition comprising a peptide comprising amino acids 24-164 of the IL-31 sequence as set forth in SEQ ID NO:
- 1 to the subject, wherein the cancer or tumor is angiogenesis-dependent and wherein the peptide is not a fused protein, thereby treating cancer and/or reducing or preventing metastasis.
A method for treating cancer and/or preventing or reducing metastasis of a tumor in a subject comprising the step of administering a composition comprising a fused protein consisting essentially of a peptide comprising amino acids 24-164 of IL-31 as set forth in SEQ ID NO:
- 1 and an immunoglobulin heavy chain to the subject, wherein the cancer or tumor is angiogenesis-dependent, thereby treating cancer and/or reducing or preventing metastasis.
Dependencies are inferred from the claim text.